(주)아이랩

{
  "address": "경기도 성남시",
  "ceo_name": "허태회, 오태권",
  "certificate": [
    {
      "cert_number": "20180300273",
      "changes": "",
      "disclosure_date": "2018-04-26",
      "first_cert_date": "2018-04-26",
      "no": "1",
      "type": "벤처투자유형",
      "valid_period": "2018-04-26 ~ 2020-04-25"
    },
    {
      "cert_number": "20200300549",
      "changes": "",
      "disclosure_date": "2020-05-07",
      "first_cert_date": "2018-04-26",
      "no": "2",
      "type": "벤처투자유형",
      "valid_period": "2020-04-26 ~ 2022-04-25"
    },
    {
      "cert_number": "20220713020006",
      "changes": "",
      "disclosure_date": "2022-07-13",
      "first_cert_date": "2018-04-26",
      "no": "3",
      "type": "연구개발유형",
      "valid_period": "2022-04-26 ~ 2025-04-25"
    },
    {
      "cert_number": "20250701020004",
      "changes": "",
      "disclosure_date": "2025-07-01",
      "first_cert_date": "2018-04-26",
      "no": "4",
      "type": "연구개발유형",
      "valid_period": "2025-04-26 ~ 2028-04-25"
    }
  ],
  "company_name": "(주)아이랩",
  "corp_no": "121111-*******",
  "financials": {
    "2022": {
      "capital_stock": 182205000,
      "cost_of_sales": 0,
      "current_assets": 16407890000,
      "current_liabilities": 1005359000,
      "gross_profit": 98182000,
      "net_income": -9754301000,
      "net_income_bs": -9754300000,
      "non_current_assets": 3542607000,
      "non_current_liabilities": 338626000,
      "non_operating_expenses": 30138000,
      "non_operating_income": 450280000,
      "operating_profit": -10174443000,
      "revenue": 98182000,
      "sga_expenses": 10272625000,
      "total_assets": 19950497000,
      "total_equity": 18606512000,
      "total_liabilities": 1343985000
    },
    "2023": {
      "capital_stock": 85695000,
      "cost_of_sales": 0,
      "current_assets": 8941115000,
      "current_liabilities": 62015962000,
      "gross_profit": 24545000,
      "net_income": -14578547000,
      "net_income_bs": -14578548000,
      "non_current_assets": 3643224000,
      "non_current_liabilities": 409383000,
      "non_operating_expenses": 6394234000,
      "non_operating_income": 443489000,
      "operating_profit": -8627802000,
      "revenue": 24545000,
      "sga_expenses": 8652348000,
      "total_assets": 12584339000,
      "total_equity": -49841006000,
      "total_liabilities": 62425345000
    },
    "2024": {
      "capital_stock": 85695000,
      "cost_of_sales": 0,
      "current_assets": 8793284000,
      "current_liabilities": 67762051000,
      "gross_profit": 0,
      "net_income": -5903656000,
      "net_income_bs": -5903656000,
      "non_current_assets": 3594370000,
      "non_current_liabilities": 447273000,
      "non_operating_expenses": 7318285000,
      "non_operating_income": 6666489000,
      "operating_profit": -5251860000,
      "revenue": 0,
      "sga_expenses": 5251860000,
      "total_assets": 12387654000,
      "total_equity": -55821669000,
      "total_liabilities": 68209323000
    }
  },
  "industry": "의학 및 약학 연구개발업",
  "investment": [
    {
      "amount": "4,498,950,000",
      "changes": "4,498,950,000",
      "date": "2018-06-29"
    }
  ],
  "main_products": "류마티스관절염 치료제",
  "phone": "02-6952-****",
  "years": [
    2024,
    2023,
    2022
  ]
}